Cargando…

Atypical PKC: therapeutic target for Alzheimer’s?

Detalles Bibliográficos
Autores principales: Farese, Robert V., Sajan, Mini P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339803/
https://www.ncbi.nlm.nih.gov/pubmed/30573704
http://dx.doi.org/10.18632/aging.101730
_version_ 1783388696644419584
author Farese, Robert V.
Sajan, Mini P.
author_facet Farese, Robert V.
Sajan, Mini P.
author_sort Farese, Robert V.
collection PubMed
description
format Online
Article
Text
id pubmed-6339803
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-63398032019-01-28 Atypical PKC: therapeutic target for Alzheimer’s? Farese, Robert V. Sajan, Mini P. Aging (Albany NY) Editorial Impact Journals 2018-12-20 /pmc/articles/PMC6339803/ /pubmed/30573704 http://dx.doi.org/10.18632/aging.101730 Text en Copyright © 2018 Farese and Sajan http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY) 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Farese, Robert V.
Sajan, Mini P.
Atypical PKC: therapeutic target for Alzheimer’s?
title Atypical PKC: therapeutic target for Alzheimer’s?
title_full Atypical PKC: therapeutic target for Alzheimer’s?
title_fullStr Atypical PKC: therapeutic target for Alzheimer’s?
title_full_unstemmed Atypical PKC: therapeutic target for Alzheimer’s?
title_short Atypical PKC: therapeutic target for Alzheimer’s?
title_sort atypical pkc: therapeutic target for alzheimer’s?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339803/
https://www.ncbi.nlm.nih.gov/pubmed/30573704
http://dx.doi.org/10.18632/aging.101730
work_keys_str_mv AT fareserobertv atypicalpkctherapeutictargetforalzheimers
AT sajanminip atypicalpkctherapeutictargetforalzheimers